Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announces that AstraZeneca has ...
College of Nursing and Health Professions’ (CNHP) second cohort in the accelerated Bachelor of Science in Nursing (ABSN) program received a 100 percent pass rate–on their first attempt–on the National ...